Strain AI vs Vivid iq
AI Verdict
Choose Strain AI if…
Choose Strain AI if you primarily need to augment your existing cardiac ultrasound workflow with automated Global Longitudinal Strain (GLS) analysis. This tool is ideal for facilities focused on enhancing diagnostic accuracy for heart failure, cardiotoxicity, or hypertrophy by integrating AI-powered interpretation directly with their current ultrasound devices.
View Strain AI →Choose Vivid iq if…
Choose Vivid iq if you require a new, highly portable, and comprehensive cardiovascular ultrasound system with advanced 2D and 4D imaging capabilities. This system is best suited for clinicians needing a versatile diagnostic tool for a broad range of cardiac assessments, especially in settings where mobility and a full suite of imaging and quantification tools are paramount.
View Vivid iq →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Strain AI | Vivid iq |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor for current pricing |
| Deployment | On-device AI, operates without internet connection. | On-premise (device) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Strain AIStrain AI (Tool A) is designed as AI-powered software that integrates with existing ultrasound devices and provides real-time, on-device insights without manual image interpretation for Global Longitudinal Strain (GLS) measurements. This focus on automating a specific, complex task directly enhances usability by simplifying the diagnostic workflow. Vivid iq (Tool B) is a comprehensive ultrasound system with AI features, but its description doesn't emphasize the AI's contribution to simplifying specific tasks as strongly as Tool A does for GLS.
Clinical Value
Strain AIBoth tools are FDA-cleared. Strain AI (Tool A) offers a highly specific and clinically critical function: measuring Global Longitudinal Strain (GLS) to aid in detecting heart failure and cardiotoxicity. This addresses a well-defined clinical need with a quantitative, AI-driven solution. Vivid iq (Tool B) provides broader high-resolution imaging and advanced quantification, but Tool A's targeted approach to a challenging diagnostic metric gives it a more distinct and explicit clinical value proposition for a specific problem.
Pricing & Value
Vivid iqBoth vendors require direct contact for current pricing. However, Vivid iq (Tool B) provides previously observed sale and original prices, offering potential buyers a general understanding of the investment range. Strain AI (Tool A) offers no pricing indications, making it harder for prospective customers to assess its value without direct engagement.
Enterprise Readiness
Strain AIBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating fundamental enterprise readiness. Strain AI (Tool A) stands out with its 'on-device AI' that 'operates without internet connection' and 'integrates with existing ultrasound devices.' This deployment model suggests easier integration into diverse healthcare IT environments with minimal network dependencies, enhancing its readiness for enterprise-wide adoption.
Innovation
Strain AIStrain AI (Tool A) demonstrates innovation by specifically automating the complex measurement of Global Longitudinal Strain (GLS) using AI, delivering real-time, on-device insights without requiring manual image interpretation. This targets a precise clinical pain point with a focused AI solution. While Vivid iq (Tool B) combines AI with ultra-portability and advanced imaging, Tool A's emphasis on AI-driven automation for a difficult, specific diagnostic task represents a more distinct and potentially disruptive AI innovation in the workflow.
Support & Docs
Vivid iqWhile both companies offer customer support channels, GE HealthCare (Tool B's parent company) is a large, established global medical technology leader with an extensive and mature support infrastructure. Their website provides dedicated resource pages, various contact options for different types of assistance, and a wide array of documentation including brochures, white papers, and technical support information for Vivid iq. Exo (Tool A's parent company) also offers a support center with email, phone, and ticket submission, and lists user manuals for other products, but the scale and depth of GE HealthCare's established support network are generally more comprehensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Strain AI | Vivid iq |
|---|---|---|
| Name | Strain AI | Vivid iq |
| Company | Exo | GE Medical Systems Ultrasound and Primary Care Diagnostics |
| Description | Exo's FDA-cleared Strain AI is an AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. | GE HealthCare's Vivid iq is an AI-powered, ultra-portable cardiovascular ultrasound system offering high-resolution 2D and 4D imaging with advanced quantification tools for efficient and accurate diagnostics across various medical specialties. |
| Primary Function | Analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS) for assessing heart function and detecting conditions like heart failure and cardiotoxicity. | Ultra-portable cardiovascular ultrasound system offering high-resolution 2D and 4D imaging with advanced quantification tools. |
| Specialties | Cardiology, Oncology, Radiology | Cardiology, Emergency Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Strain AI and Vivid iq.